Back
Berkshire Hathaway Vs. Novo Nordisk AS Industry Stock Comparison
Sell
25
BRK.A
Berkshire Hathaway
Last Price:
$679,250.00
Seasonality Move:
7.22%
Sell
28
NVO
Novo Nordisk AS
Last Price:
$86.35
Seasonality Move:
6.58%
Sell
25
Berkshire Hathaway (BRK.A)
is a Sell
Is Berkshire Hathaway a Buy, Sell or Hold?
-
The current Berkshire Hathaway [BRK.A] share price is $684,908.50. The Score for BRK.A is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
BRK.A is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $87.37. The Score for NVO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRK.A Stock Price Chart
What is Berkshire Hathaway's stock price today?
-
The Berkshire Hathaway share price today is $684,908.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.A is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.37Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
BRK.A Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4645.2 | Sell |
Relative Strength Index (14 RSI): | 44.21 | Sell |
Chaikin Money Flow: | 137 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (697081.77 - 697111.77) | Sell |
Bollinger Bands (100): | (687898.66 - 687930.66) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.45 | Sell |
Relative Strength Index (14 RSI): | 26.67 | Sell |
Chaikin Money Flow: | -3631078 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (95.05 - 111.89) | Sell |
Bollinger Bands (100): | (104.32 - 131.06) | Sell |
BRK.A Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 681572.63 | Buy |
20-day SMA: | 692371.06 | Sell |
50-day SMA: | 694515.37 | Sell |
200-day SMA: | 655722.56 | Buy |
8-day EMA: | 684756.1 | Buy |
20-day EMA: | 689514.87 | Sell |
50-day EMA: | 691315.12 | Sell |
200-day EMA: | 655823.53 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.19 | Sell |
20-day SMA: | 103.12 | Sell |
50-day SMA: | 106.79 | Sell |
200-day SMA: | 125.34 | Sell |
8-day EMA: | 92.94 | Sell |
20-day EMA: | 99.66 | Sell |
50-day EMA: | 106.73 | Sell |
200-day EMA: | 116.9 | Sell |
Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates
-
Analysts estimate an earnings increase this quarter of $676.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $4,176.34 per share, and an increase next year of $327.41 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.
Berkshire Hathaway Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |